Study Title
The overall aim of this pilot study is to prospectively monitor programmed death-ligand 1 (PD-L1) expression dynamics in vivo, during neoadjuvant chemoradiotherapy (CRT) or short-course preoperative radiotherapy (SCPRT) in rectal and esophageal cancer by a positron emission tomography (PET) imaging approach.
Study Details
Description:
Programmed Death-ligand 1 Positron Emission Tomography Imaging During Neoadjuvant (Chemo)radiothErapy in Esophageal and Rectal Cancer (PETNEC): a Prospective Non-randomized Open-label Single-center Pilot Study
Sponsor:
Johannes Laengle, MD, PhD
Contacts:
Johannes Laengle, MD, PhDjohannes.laengle@meduniwien.ac.at
+43140400 69260
Michael Bergmann, MDmichael.bergmann@meduniwien.ac.at
+43140400 69260
Government Study Link:
NCT04564482 - Click here to see study onClinicalTrials.gov